BDMD Stock Analysis: Buy, Sell, or Hold?
BDMD - Baird Medical Investment Holdings Ltd Ordinary Share
$1.10
0.02 (1.85%)
▲
5d:
-5.98%
30d:
-6.78%
90d:
-17.91%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When BDMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BDMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BDMD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDMD is currently trading at $1.10, which is considered oversold relative to its 30-day fair value range of $1.10 to $1.18. The stock's valuation (Forward PE: 7.9) is in line with its historical norms (8.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.20.
Market Sentiment: BDMD scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.20.
Market Sentiment: BDMD scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.10 -
$1.18
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 263.6% below Wall St target ($4.00)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.10 -
$1.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.05
Resistance Level
$1.20
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.86
Wall Street Target
$4.00
(+263.6%)
Revenue Growth (YoY)
24.6%
Earnings Growth (YoY)
-0.3%
Profit Margin
-64.9%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
7.9 vs 8.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$1.09
(-1%)
2-Year Target
$1.09
(-1%)
3-Year Target
$1.08
(-2%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
$1.10
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 40.0%)
$7.75
(+604%)
Base:
(SPY PE: 7.9, Growth: 40.0%)
$3.02
(+174%)
Bear:
(PE: 6.7, Growth: 40.0%)
$2.57
(+133%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.9 to 8.0
Stabilization Target:
$1.12
(+1.8%)
PE Expansion Potential:
+1.8%
Share & Embed Analysis
Last updated: September 13, 2026 2:39 PM ET
Data refreshes hourly during market hours. Next update: 3:39 PM
Data refreshes hourly during market hours. Next update: 3:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |